TABLE 3.
VGCV 450 mg/day (n = 200) | VGCV 900 mg/day (n = 25) | P Value | |
---|---|---|---|
Leukopenia | 151 (76) | 20 (80) | 0.66 |
VGCV stopped early | 12 (6) | 0 | 0.37 |
G‐CSF use | 12 (6) | 2 (8) | 0.65 |
WBC nadir | 2.5 (1.7‐3.2) | 2.3 (1.7‐3.0) | 0.35 |
Data are given as n (%) or median (IQR).
Reproduced with permission from Liver Transplantation. 10 Copyright 2018, American Association for the Study of Liver Diseases.